Cardiometabolic aspects of the polycystic ovary syndrome. - Wikidata - awgldk - TriplyDB

Cardiometabolic aspects of the polycystic ovary syndrome.

Cardiometabolic aspects of the polycystic ovary syndrome.

http://www.wikidata.org/entity/Q36287892

about

Poly Cystic Ovarian Syndrome: An Updated Overview Features of Polycystic Ovary Syndrome in adolescence Review of nonalcoholic fatty liver disease in women with polycystic ovary syndrome Polycystic Ovary Syndrome: Important Underrecognised Cardiometabolic Risk Factor in Reproductive-Age Women History of infertility and risk of type 2 diabetes mellitus: a prospective cohort study Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications.Nonalcoholic fatty liver disease and polycystic ovary syndrome.Reproductive neuroendocrine dysfunction in polycystic ovary syndrome: insight from animal models Low serum cartonectin/CTRP3 concentrations in newly diagnosed type 2 diabetes mellitus: in vivo regulation of cartonectin by glucose.Insulin dynamics in young women with polycystic ovary syndrome and normal glucose tolerance across categories of body mass index Effect of vitamin D supplementation on insulin kinetics and cardiovascular risk factors in polycystic ovarian syndrome: a pilot study.Higher circulating leukocytes in women with PCOS is reversed by aerobic exercise.The role of polycystic ovary syndrome in reproductive and metabolic health: overview and approaches for treatment.Liraglutide improves hypertension and metabolic perturbation in a rat model of polycystic ovarian syndrome.Trend of Cardio-Metabolic Risk Factors in Polycystic Ovary Syndrome: A Population-Based Prospective Cohort Study.Targets to treat androgen excess in polycystic ovary syndrome.Genotype, B-vitamin status, and androgens affect spaceflight-induced ophthalmic changes.Serum uric acid in relation to endogenous reproductive hormones during the menstrual cycle: findings from the BioCycle study Targets to treat metabolic syndrome in polycystic ovary syndrome Prenatal programming: adverse cardiac programming by gestational testosterone excess.Hyperandrogenemia predicts metabolic phenotype in polycystic ovary syndrome: the utility of serum androstenedione.Polycystic ovary syndrome as a paradigm for prehypertension, prediabetes, and preobesity.Clinical Scenario of the Metabolic Syndrome.Obstructive sleep apnoea and polycystic ovary syndrome: A comprehensive review of clinical interactions and underlying pathophysiology.Aspects of Cardiometabolic Risk in Women with Polycystic Ovary Syndrome.Calcitriol attenuates cardiac remodeling and dysfunction in a murine model of polycystic ovary syndrome.Steroid hormone profiling in obese and nonobese women with polycystic ovary syndrome.Correlation of HbA1C Levels With Body Mass Index in Newly Diagnosed Polycystic Ovary Syndrome Cardiovascular disease in polycystic ovary syndrome.Macroscopic and microscopic findings of the placenta in women with polycystic ovary syndrome.AKR1C3-Mediated Adipose Androgen Generation Drives Lipotoxicity in Women With Polycystic Ovary Syndrome.Insulin resistance in nonobese Japanese women with polycystic ovary syndrome is associated with poorer glucose tolerance, delayed insulin secretion, and enhanced insulin response.Combined oral contraceptives and/or antiandrogens versus insulin sensitizers for polycystic ovary syndrome: a systematic review and meta-analysis.Assessment of the body composition of patients with polycystic ovary syndrome using dual-energy X-ray absorptiometry.Differential effects of age and sex on insulin sensitivity and body composition in adolescent offspring of women with type 1 diabetes: results from the EPICOM study.Sex differences in sleep apnea and comorbid neurodegenerative diseases.Correlation between plasminogen activator inhibitor-1 (PAI-1) promoter 4G/5G polymorphism and metabolic/proinflammatory factors in polycystic ovary syndrome.Polycystic ovary syndrome throughout a woman's life.Metabolic syndrome, hypertension, and hyperlipidemia in mothers, fathers, sisters, and brothers of women with polycystic ovary syndrome: a systematic review and meta-analysis.Effect of meal frequency on glucose and insulin levels in women with polycystic ovary syndrome: a randomised trial.

P2860

Q26752564-03410A28-C657-4850-BBE6-BBAB901285EE Q26782435-81C5F2B7-8B93-459B-BBC8-E5DBE99DE6D4 Q26828765-A14331BE-8E4A-405C-85DE-237B221CF607 Q27021307-FFAA4B95-4B92-4E91-A7D1-1B586F5E487B Q28392981-22A6E0B4-342F-4F9E-B1A4-51AC444A0331 Q33569169-84F2AEAF-69AC-422A-9788-93F2932667C4 Q33886930-B92572D7-198F-49A1-B446-F945ABE0A2DC Q34244204-39EDE352-8343-49AB-9330-6552A1E0BFED Q34542106-CBFEC72C-D43E-454E-B692-9775D039C34C Q35140103-5207028D-F87B-4681-83DC-2D39C179A8C7 Q35575366-D5965CA8-F265-4DCF-B952-AC5FEAC4EEE1 Q35598333-A351B213-B4C5-47DA-8882-A5DC31C1B2D5 Q35610387-333E8F93-DFAC-4196-BDF8-2355A6670700 Q35641060-610377ED-7B1B-4E16-A1BB-862F00B6D245 Q35770685-CC3E9862-21D5-46C7-844E-ACE058B5FEF6 Q35835501-6013ED37-03CF-47BD-8267-FADA2A644402 Q36385353-1D6BEF72-B2FB-4588-A5D4-952E9C16D7AF Q36936702-DABAE3AF-4470-40F5-B513-B8EC194D965C Q36943683-E0300BD9-C10D-459B-AF6E-E85DDD896814 Q37027521-8D4F212C-7CBE-4C9C-8EB1-6161C82A3A7C Q37639062-29221483-F1AE-43E9-B903-26DD3BBFB07E Q38258968-B1A8D24E-7FC6-435E-9463-3A56B26A6761 Q39030269-608DBECE-9644-4944-B40F-5209380417CB Q39391344-FBAD9813-B41A-4E21-AD74-F2503EE5DE58 Q40252855-051C941E-53FF-4CD0-AF69-145A47B4ABAE Q40310971-0EF2D113-CAD1-4097-8428-D9BBFDBFC523 Q42621044-49B535DD-4F02-4AEC-9D85-0DDC269926EC Q42635475-48DA26A0-B4D1-4758-B79D-1C67CB90EE8F Q43543342-28F4B8C3-D322-485B-867F-429F4D71F260 Q44243871-0D657421-DDBE-40DD-B39A-ED589E162019 Q45204878-580CCE90-2FA1-4C5B-8A55-712F7A244C29 Q47118292-97D336A4-9AEA-4F16-8269-9E9FC1E029D8 Q47222891-09CF214E-B883-4E09-9317-2E2F50EBE062 Q47583268-56206785-FBEA-4E41-8A16-3D8FD021D173 Q47622006-486BF41A-8558-431D-820C-88BB1703E92B Q47652448-40D4F2A1-E50D-4D1C-9819-E8218A6C597A Q47901277-3B2A2709-2318-4EFC-ADFA-B2E6A96EA0ED Q47915318-D8529349-6CE9-4C60-9341-105B238448CE Q50056205-D42AF3B0-89E0-40FC-A4AC-B45C65DFAD69 Q51289298-7A593C09-0BBC-4661-A113-2D2BCE7E7EC0

P2860

Cardiometabolic aspects of the polycystic ovary syndrome.

http://www.wikidata.org/entity/Q36287892

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Cardiometabolic aspects of the polycystic ovary syndrome.

@ast

Cardiometabolic aspects of the polycystic ovary syndrome.

@en

type

label

Cardiometabolic aspects of the polycystic ovary syndrome.

@ast

Cardiometabolic aspects of the polycystic ovary syndrome.

@en

prefLabel

Cardiometabolic aspects of the polycystic ovary syndrome.

@ast

Cardiometabolic aspects of the polycystic ovary syndrome.

@en

P1433

Q36287892-997C4441-DEB5-44C6-BFB9-5DD5A347A96F

P1476

Q36287892-8C7ABFDC-387C-41B7-AF92-E9B8F6D4974C

P2093

Q36287892-38C38808-176D-48B0-9B9B-76521F9F239B

Q36287892-59503CB6-0B2A-44A3-9248-4FA2DD7E6969

Q36287892-B8BC9104-23AD-486D-8957-10246079CA46

Q36287892-DACEAE52-72B7-4D09-A550-8259D0E79685

Q36287892-EF330DAA-5952-4FE1-92EE-4FAFD17E904F

Q36287892-FC1376B3-0B25-4B20-B73E-2D97CC5B6B88

P2860

Q36287892-00771189-BA37-4DAE-9CBA-F7481AE430E9

Q36287892-00BD90B5-907A-40E4-8431-F0A7F0966158

Q36287892-0181CAF2-8745-4751-8118-FEC8D7642822

Q36287892-0281993A-AE6D-4855-A219-2F4D6E6D36B9

Q36287892-02AB8E35-6478-43A5-955C-DDC23A2E2085

Q36287892-03E2E895-EEFB-4DBD-A0D5-9D2BD0706A18

Q36287892-04DE09BD-558D-4953-813A-46E171992E29

Q36287892-0591CFC3-18B2-4412-935E-EF53089CCCA4

Q36287892-06C459BD-4739-4CDE-B3C7-03E2E53ADCD3

Q36287892-0702CD94-1C38-498A-A68A-27365454FDAB

P304

Q36287892-69C4952F-6856-4BD9-955F-5CFF51EA9BE2

P31

Q36287892-DC9077DA-013C-40B9-A0B3-A1054AD80D0D

P356

Q36287892-93C64BBF-C1E1-4E51-9211-69417E58C719

P433

Q36287892-30BEFBB4-6361-4957-AE2C-39714C61A166

P478

Q36287892-32B63ACC-C16F-49D8-86BD-D453380179C1

P50

Q36287892-DFA9330A-1219-46E3-BA11-F2D69AA61D26

P577

Q36287892-EFAAC89F-CDD4-4514-AC75-B21FCF18E896

P698

Q36287892-09040E6B-A07A-4B96-80B2-F5FED12965CF

P921

Q36287892-3155D4A8-3CB6-4EFA-8703-E91764254CF1

P932

Q36287892-1600BCDF-AB8D-42A5-8314-6E02FFB9B5AA

P356

P1433

Endocrine Reviews

P1476

Cardiometabolic aspects of the polycystic ovary syndrome

@en

P2093

Bee K Tan

http://www.w3.org/2001/XMLSchema#string

Harpal S Randeva

http://www.w3.org/2001/XMLSchema#string

Hendrik Lehnert

http://www.w3.org/2001/XMLSchema#string

John E Nestler

http://www.w3.org/2001/XMLSchema#string

Konstantinos Lois

http://www.w3.org/2001/XMLSchema#string

Naveed Sattar

http://www.w3.org/2001/XMLSchema#string

P2860

Metformin in polycystic ovary syndrome: systematic review and meta-analysis

Clomiphene, Metformin, or Both for Infertility in the Polycystic Ovary Syndrome

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility

Lifestyle changes in women with polycystic ovary syndrome

Steroidal contraceptives: effect on carbohydrate metabolism in women without diabetes mellitus

Insulin-sensitising drugs versus the combined oral contraceptive pill for hirsutism, acne and risk of diabetes, cardiovascular disease, and endometrial cancer in polycystic ovary syndrome

Insulin-sensitising drugs (metformin, troglitazone, rosiglitazone, pioglitazone, D-chiro-inositol) for polycystic ovary syndrome

Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor

Obesity and insulin resistance

P304

812-841

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1210/ER.2012-1003

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

33

http://www.w3.org/2001/XMLSchema#string

P50

Martin O. Weickert

P577

2012-07-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22829562

http://www.w3.org/2001/XMLSchema#string

P921

polycystic ovary syndrome

P932

3461136

http://www.w3.org/2001/XMLSchema#string